<<

Tamarind/Tropisetron 1777

Profile Tropisetron (BAN, rINN) tensive metabolisers and up to 45 hours in poor metab- and tiemonium metilsulfate are quaternary olisers. Clearance is also reduced in patients with renal ammonium antimuscarinics with peripheral effects similar to Tropisétron; Tropisetrón; Tropisetroni; Tropisetronum. impairment. those of (p.1219) and are used in the relief of visceral 1αH,5αH-Tropan-3α-yl indole-3-carboxylate. spasms. Трописетрон Tiemonium metilsulfate is given in an oral dose of 100 to 300 mg Uses and Administration C H N O = 284.4. daily in divided doses. A dose of 5 mg has been given three times 17 20 2 2 Tropisetron is a 5-HT3 antagonist with an antiemetic daily by intramuscular or slow intravenous injection. Tiemonium CAS — 89565-68-4. action similar to that of ondansetron (p.1757). It is used metilsulfate has also been given as a rectal suppository in daily ATC — A04AA03. in the prevention of nausea and vomiting induced by doses of 20 to 40 mg. ATC Vet — QA04AA03. cytotoxic therapy and in the treatment and prevention Tiemonium iodide has been used similarly. of postoperative nausea and vomiting (p.1700). Preparations CH Tropisetron is given as the hydrochloride by slow intra- Proprietary Preparations (details are given in Part 3) 3 venous injection or infusion, or orally. Doses are ex- Belg.: Visceralgine†; Fr.: Visceralgine; Indon.: Visceralgine. N pressed in terms of tropisetron base; 5.64 mg of tropi- Multi-ingredient: Belg.: Asodal; Fr.: Colchimax; Visceralgine Forte†; Venez.: Bort†. setron hydrochloride is equivalent to about 5 mg of tropisetron base. H N For the prophylaxis of acute nausea and vomiting as- (rINN) sociated with cytotoxic chemotherapy a single dose of Bromuro de timepidio; SA-504; Timepidii Bromidum; Timépid- O 5 mg may be given by slow intravenous injection or ium, Bromure de. 3-[Di-(2-thienyl)methylene]-5-methoxy-1,1- infusion on the day of treatment, shortly before chemo- dimethylpiperidinium bromide monohydrate. O therapy. The injection is given over not less than 1 Тимепидия Бромид minute; it may be given into a running infusion. For infusion, it is diluted into 100 mL of a suitable infusion C17H22BrNOS2,H2O = 418.4. CAS — 35035-05-3. Tropisetron Hydrochloride (BANM, rINNM) fluid (such as sodium chloride 0.9% or glucose 5%), ATC — A03AB19. Hidrocloruro de tropisetrón; ICS-205-930; Tropisétron, chlorhy- and given over 15 minutes. Subsequent doses of 5 mg ATC Vet — QA03AB19. drate de; Tropisetroni hydrochloridum. daily are given orally, in the morning at least one hour Трописетрона Гидрохлорид before food, for a further 5 days.

C17H20N2O2,HCl = 320.8. Children over 2 years of age may be given CAS — 105826-92-4. 200 micrograms/kg (maximum dose 5 mg) before CH3 ATC — A04AA03. chemotherapy, by intravenous injection over at least 1 H3C N+ S ATC Vet — QA04AA03. minute, or by infusion (at a concentration of Br- Pharmacopoeias. In Eur. (see p.vii). 50 micrograms/mL in a suitable infusion fluid). In chil- Ph. Eur. 6.2 (Tropisetron Hydrochloride). A white or almost dren weighing less than 25 kg the same dose may be white powder. Freely soluble or soluble in water; sparingly solu- given intravenously once daily for up to a further 4 3C OH S ble in ; very slightly soluble in dichloromethane. days as required. In those weighing more than 25 kg, a dose of 5 mg may be given orally once daily for up to Adverse Effects and Precautions a further 5 days; if oral dosage is not possible the same Pharmacopoeias. In Jpn. As for Ondansetron, p.1757. Fatigue, abdominal pain, dose may be given intravenously. and diarrhoea may also occur. Visual hallucinations, Profile and an increase in blood pressure in patients with pre- For the treatment of postoperative nausea and vomit- Timepidium bromide is a quaternary ammonium antimuscarinic ing in adults 2 mg may be given by slow intravenous with peripheral actions similar to those of atropine (p.1219). It existing hypertension, have been noted at high repeat- has been given for the symptomatic treatment of visceral spasms ed doses. ECG changes such as prolongation of QT in- injection (over not less than 30 seconds), or by infusion in usual oral doses of 30 mg three times daily. It has also been terval have been noted with high-dose intravenous tro- (over 15 minutes), within 2 hours of the end of anaes- given by subcutaneous, intramuscular, and intravenous injection pisetron. The drug should therefore be used with thesia. For prophylaxis, the same dose may be given in a dose of 7.5 mg. caution in patients with cardiac rhythm or conduction shortly before induction of anaesthesia. Urinary metabolites of timepidium may cause a reddish colora- tion of the urine. disturbances. Care should be taken when driving or op- ◊ References. erating machinery. No dosage reduction is considered 1. Lee CR, et al. Tropisetron: a review of its pharmacodynamic and Preparations necessary in renal or hepatic impairment despite possi- pharmacokinetic properties, and therapeutic potential as an an- tiemetic. Drugs 1993; 46: 925–43. Proprietary Preparations (details are given in Part 3) ble reductions in clearance. 2. Simpson K, et al. Tropisetron: an update of its use in the preven- Indon.: Sesden; Jpn: Sesden; Singapore: Sesden†. tion of chemotherapy-induced nausea and vomiting. Drugs Carcinogenicity. The manufacturer (Novartis, UK) has report- 2000; 59: 1297–1315. ed an increased incidence of hepatic neoplasms in male mice giv- en high doses of tropisetron but it is suggested that these effects Anxiety disorders. A dose-dependent anxiolytic effect was re- Chloride (BAN, rINNM) are both species and sex specific. ported for tropisetron when studied in patients with generalised 1 anxiety, but clinical evidence for the benefit of 5-HT3 antago- Cloruro de tridihexetilo; Tridihexéthyl, Chlorure de; Tridihexe- Effects on the cardiovascular system. For a discussion of nists in anxiety disorders is lacking.2 thyli Chloridum. (3-Cyclohexyl-3-hydroxy-3-phenylpropyl)tri- the effects of 5-HT antagonists on the cardiovascular system, 3 1. Lecrubier Y, et al. A randomized double-blind placebo-control- ethylammonium chloride. see under Ondansetron, p.1757. led study of tropisetron in the treatment of outpatients with gen- Тридигексетила Хлорид eralized anxiety disorder. Psychopharmacology (Berl) 1993; Interactions 112: 129–33. C21H36ClNO = 354.0. 2. Greenshaw AJ, Silverstone PH. The non-antiemetic uses of sero- CAS — 60-49-1 (tridihexethyl); 4310-35-4 (tridihexethyl Drugs that induce or inhibit hepatic enzymes may af- tonin 5-HT receptor antagonists: clinical pharmacology and chloride); 125-99-5 (tridihexethyl iodide). fect plasma concentrations of tropisetron. Licensed therapeutic applications. Drugs 1997; 53: 20–39. ATC — A03AB08. product information considers that any changes are Fatigue. Tropisetron has been reported to be of benefit in pa- ATC Vet — QA03AB08. usually unlikely to be clinically relevant with the rec- tients with chronic fatigue, see under Uses and Administration of ommended doses. Ondansetron, p.1758. Pain. For reference to the use of tropisetron in various painful CH Tropisetron should be used with caution with anti- 3 arrhythmics, beta blockers, or drugs likely to prolong syndromes, see under Uses and Administration of Ondansetron, p.1758. HO + the QT interval, including those likely to cause electro- N CH3 − lyte disturbances (see also p.1757). Pruritus. Tropisetron and other 5-HT3 antagonists have been Cl investigated for the management of pruritus (see under On- dansetron, p.1758). CH3 Pharmacokinetics Tropisetron is well absorbed after oral doses. Peak Preparations plasma concentrations are achieved within 3 hours. Proprietary Preparations (details are given in Part 3) Absolute bioavailability depends on the dose since Arg.: Navoban; Austral.: Navoban; Austria: Navoban; Belg.: Novaban; Braz.: Navoban†; Chile: Navoban; Cz.: Navoban†; Denm.: Navoban; NOTE. Tridihexethyl Iodide is rINN. first-pass metabolism is saturable. It is 71% bound to Fin.: Navoban; Fr.: Navoban; Ger.: Navoban; Gr.: Navoban; Hong Kong: plasma proteins. Tropisetron is metabolised by hydrox- Navoban; Hung.: Navoban; Indon.: Navoban; Setrovel; Israel: Navoban†; Profile Ital.: Navoban; Jpn: Navoban; Malaysia: Navoban; Mex.: Navoban; Tridihexethyl chloride is a quaternary ammonium antimuscarin- ylation and conjugation, and metabolites are excreted Neth.: Novaban; Norw.: Navoban; NZ: Navoban; Philipp.: Navoban; ic with peripheral effects similar to those of atropine (p.1219). It mainly in the urine with a small amount in the faeces. Pol.: Navoban; Port.: Navoban; Rus.: Navoban (Навобан); Tropindol (Тропиндол)†; S.Afr.: Navoban; Spain: Navoban; Saronil; Swed.: Na- has been used as an adjunct in the treatment of peptic ulcer dis- The cytochrome P450 isoenzyme CYP2D6 is involved voban; Switz.: Navoban; Thai.: Navoban; Turk.: Navoban; UK: Navoban; ease. in tropisetron metabolism, and shows genetic polymor- Venez.: Navoban. phism. The elimination half-life is about 8 hours in ex- The symbol † denotes a preparation no longer actively marketed The symbol ⊗ denotes a substance whose use may be restricted in certain sports (see p.vii)